DERM looking bullish againLooking to keep trending over the medium term. Looks like it is already reversing from the latest correction. From the last earnings and price action, it seems to be a lot more major upside for this stock.
−0.23USD
−3.85 MUSD
79.18 MUSD
6.65 M
About Journey Medical Corporation
Sector
CEO
Claude Maraoui
Headquarters
Scottsdale
Website
Employees (FY)
58
Founded
2014
ISIN
US48115J1097
FIGI
BBG00ZWVDRK2
Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.
A bullish candlestick pattern One of the most bullish candlestick trading patterns ive ever seen, in order:
- Correction after first large pump
- Reversal doji
- three green candlesticks with increasing size and almost no shadow
In addition to my previous idea, upside potential is very present.
Dermatology Pump incomingThe increase in buy volume (large volume buys) are stacking into this stock. A purely technical play but the trend+volume leads to the conclusion that a large pump upwards is coming up in the near future (3-6 months)
short term tradeBreak out of a solid bottom formation with high and constant volume. From a technical standpoint the prospect looks very good for continued upward action in the short term
DERM | Good Entry Point | OversoldJourney Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosi
Another Nice Short to End Your WeekStrong price action because of failed drug trials for a competitor (ANAB)
Shorting here at 8.97. Targetting 5-7. Will place a trailing stop at 7.
$derm HIGH volume and Float.$Derm HIGH volume along with great float/demand = LONG
Its pasting previous highs and throughout the daily breakouts we have learned it will continue due to demand and volume.
DERM good R/R at support up trend. PT 12.00 NASDAQ:DERM
DERM has been bouncing off this trendline since April and it doesn't have a reason to fail now with an ER beat which was the first beat in the last. Great Risk / Reward setup here to get back up to 12.00 dollars and if we get that 200 MA break we can shoot back up to 20 dollars easy wi
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of DERM is 3.48 USD — it has decreased by 2.79% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Journey Medical Corporation stocks are traded under the ticker DERM.
Journey Medical Corporation is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
DERM stock is 7.06% volatile and has beta coefficient of −0.43. Check out the list of the most volatile stocks — is Journey Medical Corporation there?
One year price forecast for Journey Medical Corporation has a max estimate of 8.50 USD and a min estimate of 8.00 USD.
DERM earnings for the last quarter are 0.99 USD per share, whereas the estimation was −0.16 USD resulting in a 738.71% surprise. The estimated earnings for the next quarter are −0.09 USD per share. See more details about Journey Medical Corporation earnings.
Journey Medical Corporation revenue for the last quarter amounts to 34.50 M USD despite the estimated figure of 16.90 M USD. In the next quarter revenue is expected to reach 14.95 M USD.
Yes, you can track Journey Medical Corporation financials in yearly and quarterly reports right on TradingView.
DERM stock has fallen by 22.15% compared to the previous week, the month change is a 7.69% fall, over the last year Journey Medical Corporation has showed a 109.64% increase.
DERM net income for the last quarter is −2.14 M USD, while the quarter before that showed 16.79 M USD of net income which accounts for −112.76% change. Track more Journey Medical Corporation financial stats to get the full picture.
Today Journey Medical Corporation has the market capitalization of 71.36 M, it has increased by 20.88% over the last week.
No, DERM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, DERM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Journey Medical Corporation stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 58.00 employees. See our rating of the largest employees — is Journey Medical Corporation on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Journey Medical Corporation technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Journey Medical Corporation stock shows the sell signal. See more of Journey Medical Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Journey Medical Corporation future price: according to them, DERM price has a max estimate of 8.50 USD and a min estimate of 8.00 USD. Read a more detailed Journey Medical Corporation forecast: see what analysts think of Journey Medical Corporation and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Journey Medical Corporation EBITDA is 5.43 M USD, and current EBITDA margin is 6.22%. See more stats in Journey Medical Corporation financial statements.